Beijing Tongren Hospital, Beijing, 100730, China.
Capital Medical University, Beijing, 100730, China.
BMC Ophthalmol. 2021 Mar 16;21(1):137. doi: 10.1186/s12886-021-01898-3.
Tumor regression of uveal melanomas (UMs) after radiotherapy has been reported as a valuable prognostic factor for metastasis and metastatic death. But its effect on prognosis is questionable. The purpose of this study was to summarize the regression features of uveal melanoma after iodine-125 plaque brachytherapy and the relationship with prognosis.
Adult uveal melanoma patients who only received iodine-125 plaque brachytherapy between December 2009 and March 2018 at the Beijing Tongren Hospital, Capital Medical University were enrolled in this study. The regression rate was calculated as the percent change in tumor height, and each eye was classified for four main regression patterns: Decrease (D), Stable (S), Others (O), and Increase (I), according to the trend of height change. Statistical analysis was performed using one-way ANOVA and chi-square test, univariate and multivariate logistic regression, and Kaplan-Meier analysis.
A total of 139 patients was included in the study. The median follow-up was 35 months. Regression patterns status was pattern D in 65 tumors (46.8%), pattern S in 50 tumors (36.0%), pattern O in 6 tumors (4.3%), and pattern I in 18 tumors (12.9%). Reductions of tumor mean height for each follow-up visit were 5.26% (3 months), 10.66% (6 months), 9.37% (12 months), and 14.68% (18 months). A comparison (D vs. S vs. O vs. I) revealed the preoperative height of pattern I was significantly lower than the pattern D, S and O (mean: 7.24 vs. 7.30 vs. 6.77 vs. 5.09 mm, respectively; P = 0.037). LBD (largest basal diameter) was strongly associated with the metastasis (P = 0.03). However, an association between the tumor regression and subsequent melanoma-related metastasis and mortality could not be confirmed (P = 0.66 and P = 0.27, respectively). The tumor regression rate increased with increasing tumor height (P = 0.04) and decreased with increasing of LBD (P = 0.01).
Our study showed a lack of association between the prognosis and the regression of uveal melanomas following I-125 plaque radiotherapy. The LBD and original height of the tumor have predictive value in tumor regression rate, and LBD was positively associated with metastasis.
已有报道称,葡萄膜黑色素瘤(UM)在放疗后肿瘤消退是转移和转移死亡的有价值的预后因素。但其对预后的影响仍存在争议。本研究旨在总结碘 125 放射性敷贴治疗后葡萄膜黑色素瘤的消退特征及其与预后的关系。
选取 2009 年 12 月至 2018 年 3 月期间仅在北京同仁医院接受碘 125 放射性敷贴治疗的成人葡萄膜黑色素瘤患者,纳入本研究。肿瘤高度的消退率计算为肿瘤高度变化的百分比,根据高度变化趋势,每只眼分为四种主要的消退模式:减少(D)、稳定(S)、其他(O)和增加(I)。采用单因素方差分析和卡方检验、单因素和多因素逻辑回归、Kaplan-Meier 分析进行统计学分析。
本研究共纳入 139 例患者,中位随访时间为 35 个月。消退模式状态为:65 例(46.8%)为模式 D,50 例(36.0%)为模式 S,6 例(4.3%)为模式 O,18 例(12.9%)为模式 I。每次随访时肿瘤平均高度的减少分别为:5.26%(3 个月)、10.66%(6 个月)、9.37%(12 个月)和 14.68%(18 个月)。比较(D 比 S 比 O 比 I)发现,模式 I 的术前高度明显低于模式 D、S 和 O(平均:7.24 比 7.30 比 6.77 比 5.09mm,分别;P=0.037)。LBD(最大基底直径)与转移密切相关(P=0.03)。然而,未能证实肿瘤消退与随后的黑色素瘤相关转移和死亡率之间存在关联(P=0.66 和 P=0.27,分别)。肿瘤消退率随肿瘤高度的增加而增加(P=0.04),随 LBD 的增加而降低(P=0.01)。
本研究显示,I-125 放射性敷贴治疗后葡萄膜黑色素瘤的消退与预后之间缺乏关联。LBD 和肿瘤的原始高度对肿瘤消退率具有预测价值,且 LBD 与转移呈正相关。